BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9415013)

  • 1. Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy.
    Sato Y; Kataoka K; Matsumori A; Sasayama S; Yamada T; Ito H; Takatsu Y
    Heart; 1997 Nov; 78(5):505-8. PubMed ID: 9415013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.
    Murawaki Y; Ikuta Y; Koda M; Kawasaki H
    Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis.
    Klappacher G; Franzen P; Haab D; Mehrabi M; Binder M; Plesch K; Pacher R; Grimm M; Pribill I; Eichler HG
    Am J Cardiol; 1995 May; 75(14):913-8. PubMed ID: 7733000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan.
    Bentsen KD; Horn T; Risteli J; Risteli L; Engström-Laurent A; Hørslev-Petersen K; Lorenzen I
    Liver; 1987 Dec; 7(6):339-46. PubMed ID: 3437796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procollagen type III amino-terminal propeptide: a serum biomarker of left ventricular remodelling in paediatric dilated cardiomyopathy.
    Kaufman BD; Videon N; Zhang X; Harris MA; Shaddy RE; Goldmuntz E
    Cardiol Young; 2015 Feb; 25(2):228-36. PubMed ID: 24192074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy.
    Timonen P; Magga J; Risteli J; Punnonen K; Vanninen E; Turpeinen A; Tuomainen P; Kuusisto J; Vuolteenaho O; Peuhkurinen K
    Int J Cardiol; 2008 Mar; 124(3):293-300. PubMed ID: 17442428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating markers of collagen types I, III, and IV in patients with dilated cardiomyopathy: relationships with myocardial collagen expression.
    Nagao K; Inada T; Tamura A; Kajitani K; Shimamura K; Yukawa H; Aida K; Sowa N; Nishiga M; Horie T; Makita T; Ono K; Tanaka M
    ESC Heart Fail; 2018 Dec; 5(6):1044-1051. PubMed ID: 30273997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury.
    Suou T; Yamada S; Kobayashi J; Hoshino U; Nishimuki E; Kawasaki H
    Hepatology; 1993 Oct; 18(4):809-15. PubMed ID: 7691706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.
    Rubiś P; Wiśniowska-Śmialek S; Wypasek E; Biernacka-Fijalkowska B; Rudnicka-Sosin L; Dziewiecka E; Faltyn P; Khachatryan L; Karabinowska A; Kozanecki A; Tomkiewicz-Pająk L; Podolec P
    Inflamm Res; 2016 Dec; 65(12):941-949. PubMed ID: 27516211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy.
    Bonapace S; Rossi A; Cicoira M; Golia G; Zanolla L; Franceschini L; Conte L; Marino P; Zardini P; Vassanelli C
    Am Heart J; 2006 Jul; 152(1):93.e1-6. PubMed ID: 16824836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment.
    Kanoupakis EM; Manios EG; Kallergis EM; Mavrakis HE; Goudis CA; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE
    J Am Coll Cardiol; 2010 Jun; 55(24):2753-9. PubMed ID: 20538169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia.
    Kohno N; Yokoyama A; Hirasawa Y; Kondo K; Fujino S; Abe M; Hiwada K
    Respir Med; 1997 Oct; 91(9):558-61. PubMed ID: 9415357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum 7S collagen in various liver diseases.
    Yamada S; Suou T; Kawasaki H; Yoshikawa N
    Clin Biochem; 1992 Dec; 25(6):467-70. PubMed ID: 1335851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.
    Flevari P; Theodorakis G; Leftheriotis D; Kroupis C; Kolokathis F; Dima K; Anastasiou-Nana M; Kremastinos D
    Am Heart J; 2012 Oct; 164(4):530-7. PubMed ID: 23067911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic fibrosis in rats produced by carbon tetrachloride and dimethylnitrosamine: observations suggesting immunoassays of serum for the 7S fragment of type IV collagen are a more sensitive index of liver damage than immunoassays for the NH2-terminal propeptide of type III procollagen.
    Ala-Kokko L; Günzler V; Hoek JB; Rubin E; Prockop DJ
    Hepatology; 1992 Jul; 16(1):167-72. PubMed ID: 1618469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis.
    Hørslev-Petersen K; Bentsen KD; Halberg P; Junker P; Kivirikko KI; Majamaa K; Risteli L; Risteli J; Lorenzen I
    Clin Exp Rheumatol; 1988; 6(2):129-34. PubMed ID: 2846219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 12-month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new-onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis.
    Rubiś P; Wiśniowska-Smiałek S; Wypasek E; Rudnicka-Sosin L; Hlawaty M; Leśniak-Sobelga A; Kostkiewicz M; Podolec P
    Cytokine; 2017 Aug; 96():217-227. PubMed ID: 28460256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aminoterminal propeptide of type III procollagen and basement membrane components in serum during wound healing in man.
    Bentsen KD; Lanng C; Hørslev-Petersen K; Risteli J
    Acta Chir Scand; 1988 Feb; 154(2):97-101. PubMed ID: 3354300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procollagen type III N-peptide and type IV collagen 7S-domain in the sera of breast cancer patients.
    Narita T; Funahashi H; Satoh Y; Takagi H
    Surg Today; 1993; 23(8):682-6. PubMed ID: 8400671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy].
    Niitsu N; Umeda M
    Rinsho Ketsueki; 1994 Nov; 35(11):1267-75. PubMed ID: 7529840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.